Clinical Trial Update: VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial [Phase 2]

View source ↗

Summary

Phase 2 feasibility trial of the VentrAssist LVAD as a bridge to cardiac transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathies
• End-stage Heart Failure

Drugs mentioned

• VentrAssist LVAD

Snippet

Sponsor: Ventracor | Conditions: End-Stage Heart Failure, Cardiomyopathies | Phase 2 | Status: COMPLETED